Cibinqo Approved for Refractory, Moderate to Severe Atopic Dermatitis
The approval was based on data from the phase 3 JADE clinical trial program, which included the JADE MONO-1, JADE MONO-2, and JADE COMPARE trials.
Dermatological Disorders
Rinvoq Gains FDA Approval for Atopic Dermatitis
The approval was based on data from three phase 3 trials that evaluated the efficacy and safety of upadacitinib in patients 12 years of age and older with moderate to severe atopic dermatitis who are candidates for systemic therapy.
Clinical Challenge: History of Tick Bite
A 52-year-old woman presents with a history of a tick bite that occurred approximately 8 months ago. Can you make the correct diagnosis?
Corticosteroid Ointment Recalled Due to Bacterial Contamination
To date, the Company has not received reports of adverse events related to this recall.
Adbry Approved for Moderate to Severe Atopic Dermatitis
The approval was based on data from 3 pivotal phase 3 (ECZTRA 1-3) trials that evaluated the safety and efficacy of Adbry in 1934 adults with moderate to severe AD.
Spesolimab Clears Lesions in Generalized Pustular Psoriasis
In phase 2 trial, spesolimab cleared more lesions than placebo, but it was associated with infections, systemic drug reactions
Clinical Challenge: Itchy Rash on Legs
A 12-year-old adolescent presents with the chief complaint of a burning pruritic rash on her legs. Can you make the correct diagnosis?
Trial Evaluating Lebrikizumab Plus TCS in Atopic Dermatitis Meets Endpoints
The ADhere trial evaluated lebrikizumab in combination with topical corticosteroids in adults and adolescents with moderate to severe atopic dermatitis.
Clinical Challenge: Swollen Lips
A 16-year-old patient with an 8-year history of psoriasis presents with a swollen lip. Can you make the correct diagnosis?
Otezla Now Approved for Plaque Psoriasis Across All Severities
The approval was based on data from the phase 3 ADVANCE trial.
